These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8861836)

  • 1. Cytogenetic abnormalities in an in situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer.
    Teixeira MR; Pandis N; Gerdes AM; Dietrich CU; Bardi G; Andersen JA; Graversen HP; Mitelman F; Heim S
    Breast Cancer Res Treat; 1996; 38(2):177-82. PubMed ID: 8861836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families.
    Petersson C; Pandis N; Mertens F; Adeyinka A; Ingvar C; Ringberg A; Idvall I; Bondeson L; Borg A; Olsson H; Kristoffersson U; Mitelman F
    Genes Chromosomes Cancer; 1996 Jul; 16(3):185-8. PubMed ID: 8814451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer.
    Aubele MM; Cummings MC; Mattis AE; Zitzelsberger HF; Walch AK; Kremer M; Höfler H; Werner M
    Diagn Mol Pathol; 2000 Mar; 9(1):14-9. PubMed ID: 10718208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
    Hoogerbrugge N; Bult P; de Widt-Levert LM; Beex LV; Kiemeney LA; Ligtenberg MJ; Massuger LF; Boetes C; Manders P; Brunner HG
    J Clin Oncol; 2003 Jan; 21(1):41-5. PubMed ID: 12506168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 1 aneusomy, identified by interphase cytogenetics, in mammographically detected ductal carcinoma in situ of the breast.
    Harrison M; Magee HM; O'Loughlin J; Gorey TF; Dervan PA
    J Pathol; 1995 Mar; 175(3):303-9. PubMed ID: 7745499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
    J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome analysis of in situ breast cancer.
    Nielsen KV; Blichert-Toft M; Andersen J
    Acta Oncol; 1989; 28(6):919-22. PubMed ID: 2558694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic mastectomy: pathologic findings in high-risk patients.
    Khurana KK; Loosmann A; Numann PJ; Khan SA
    Arch Pathol Lab Med; 2000 Mar; 124(3):378-81. PubMed ID: 10705389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors.
    Pandis N; Teixeira MR; Gerdes AM; Limon J; Bardi G; Andersen JA; Idvall I; Mandahl N; Mitelman F; Heim S
    Cancer; 1995 Jul; 76(2):250-8. PubMed ID: 8625100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization.
    Marinho AF; Botelho M; Schmitt FC
    Pathol Res Pract; 2000; 196(4):227-33. PubMed ID: 10782466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
    Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast.
    Munn KE; Walker RA; Varley JM
    Oncogene; 1995 Apr; 10(8):1653-7. PubMed ID: 7731721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ in breast carcinogenesis.
    van Diest PJ
    J Pathol; 1999 Mar; 187(4):383-4. PubMed ID: 10398095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ.
    Murphy DS; McHardy P; Coutts J; Mallon EA; George WD; Kaye SB; Brown R; Keith WN
    Int J Cancer; 1995 Feb; 64(1):18-26. PubMed ID: 7665243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
    Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
    Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS.
    Moore E; Magee H; Coyne J; Gorey T; Dervan PA
    J Pathol; 1999 Mar; 187(4):403-9. PubMed ID: 10398098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in ductal carcinoma in situ of the breast.
    Stratton MR; Collins N; Lakhani SR; Sloane JP
    J Pathol; 1995 Feb; 175(2):195-201. PubMed ID: 7738715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for elective contralateral mastectomy with immediate bilateral reconstruction.
    Kroll SS; Miller MJ; Schusterman MA; Reece GP; Singletary SE; Ames F
    Ann Surg Oncol; 1994 Nov; 1(6):457-61. PubMed ID: 7850550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis.
    Rane SU; Mirza H; Grigoriadis A; Pinder SE
    Breast Cancer Res Treat; 2015 Aug; 153(1):101-21. PubMed ID: 26255059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.